当前位置:首页 - 行情中心 - 洁特生物(688026) - 财务分析 - 现金流量表

洁特生物

(688026)

  

流通市值:26.66亿  总市值:26.67亿
流通股本:1.40亿   总股本:1.40亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金341,622,290.02188,448,853.76503,598,801.81399,948,773.57
  收到的税费返还3,331,337.121,669,520.447,174,888.816,912,748.89
  收到其他与经营活动有关的现金21,094,089.8610,467,432.5525,304,961.4526,435,717.33
  经营活动现金流入小计366,047,717200,585,806.75536,078,652.07433,297,239.79
  购买商品、接受劳务支付的现金150,667,023.5393,717,224.31288,739,123.75241,274,478.57
  支付给职工以及为职工支付的现金70,597,685.134,639,070.97125,604,205.0690,860,689.18
  支付的各项税费29,490,945.7518,033,803.9320,209,791.4320,227,805.42
  支付其他与经营活动有关的现金31,122,649.918,497,765.5647,574,375.2771,559,900.96
  经营活动现金流出小计281,878,304.29154,887,864.77482,127,495.51423,922,874.13
  经营活动产生的现金流量净额84,169,412.7145,697,941.9853,951,156.569,374,365.66
二、投资活动产生的现金流量:
  取得投资收益收到的现金1,958,034.73---
  处置固定资产、无形资产和其他长期资产收回的现金净额--72,530.9775,000
  收到的其他与投资活动有关的现金430,125,120143,524,080376,110,600167,760,800
  投资活动现金流入小计432,083,154.73143,524,080376,183,130.97167,835,800
  购建固定资产、无形资产和其他长期资产支付的现金72,943,125.7133,654,537.29110,666,367.4442,573,250.04
  投资支付的现金--5,800,0005,800,000
  支付其他与投资活动有关的现金408,797,015.04116,093,280521,451,954.38192,387,100
  投资活动现金流出小计481,740,140.75149,747,817.29637,918,321.82240,760,350.04
  投资活动产生的现金流量净额-49,656,986.02-6,223,737.29-261,735,190.85-72,924,550.04
三、筹资活动产生的现金流量:
  吸收投资收到的现金--5,970,0001,470,000
  其中:子公司吸收少数股东投资收到的现金--5,970,0001,470,000
  筹资活动现金流入平衡项目--00
  筹资活动现金流入小计--5,970,0001,470,000
  分配股利、利润或偿付利息支付的现金4,400,190-12,319,661.5111,050,992.23
  支付其他与筹资活动有关的现金147,583.282,714.6831,960,780.132,112,617.57
  筹资活动现金流出小计4,547,773.282,714.6844,280,441.6143,163,609.8
  筹资活动产生的现金流量净额-4,547,773.2-82,714.68-38,310,441.61-41,693,609.8
四、汇率变动对现金及现金等价物的影响3,410,047.44-157,027.03-447,824.3-5,334,267.85
五、现金及现金等价物净增加额33,374,700.9339,234,462.98-246,542,300.2-110,578,062.03
  加:期初现金及现金等价物余额118,395,277.38118,395,277.38364,937,577.58364,937,577.58
  期末现金及现金等价物余额151,769,978.31157,629,740.36118,395,277.38254,359,515.55
补充资料:
  净利润47,580,111.57-72,962,545.44-
  资产减值准备-438,825.26-10,707,009.15-
  固定资产和投资性房地产折旧25,844,334.49-57,109,093.78-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧25,844,334.49-57,109,093.78-
  无形资产摊销626,861.9-1,379,853.96-
  处置固定资产、无形资产和其他长期资产的损失--167,342.79-
  固定资产报废损失54,293.88-1,805.67-
  财务费用13,968,316.54-26,916,093.6-
  投资损失-1,112,409.37-1,002,041.49-
  递延所得税456,138.92--1,326,424.03-
  其中:递延所得税资产减少456,138.92--1,326,424.03-
  存货的减少5,521,091.69--50,580,764.3-
  经营性应收项目的减少16,412,602.83--85,984,916.1-
  经营性应付项目的增加-24,586,384.98-15,308,269.9-
  现金的期末余额151,769,978.31-118,395,277.38-
  减:现金的期初余额118,395,277.38-364,937,577.58-
  现金及现金等价物的净增加额33,374,700.93--246,542,300.2-
公告日期2025-08-302025-04-262025-04-162024-10-24
审计意见(境内)标准无保留意见
TOP↑